First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
NCT06554795
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
360
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
DB-1419
Sponsor
DualityBio Inc.